Market Overview:
The global blood product market is expected to reach USD XX million by 2030, at a CAGR of XX% during the forecast period 2018-2030. The growth in this market can be attributed to factors such as rising incidence of chronic diseases, increasing demand for plasma-derived products and technological advancements in the field of blood transfusion. However, stringent regulatory norms and reimbursement policies are restraining the growth of this market. Based on type, albumin segment is projected to account for the largest share in 2018 and is expected to maintain its dominance during the forecast period. This can be attributed to its wide range of applications across different therapeutic areas. By application, immunity segment is projected to account for the largest share in 2018 and is expected to maintain its dominance during the forecast period.
Product Definition:
A blood product is a fluid that contains blood cells and plasma. Plasma is the clear, yellowish liquid portion of blood that contains proteins, electrolytes, lipids, and glucose. It also carries clotting factors and other substances needed for healing. Blood products are used to treat various medical conditions, including bleeding disorders, low platelet counts (thrombocytopenia), burns, and shock.
Albumin:
Albumin is a protein hormone made by the human body. It helps in maintaining the fluid balance, and provides resistance to hypo and hyperthermia. It also has an important role in preventing blood clots, thereby promoting effective blood flow.
Immune Globulin:
Immune Globulin is a product that contains antibodies. It is used in blood transfusion for the treatment of certain blood disorders and to prevent infections during medical procedures. The most common use of this product is in the treatment of immune thrombocytopenic purpura (ITP). ITP is characterized by an abnormal increase in platelet count due to destruction or damage to the person's immune system, which causes them bleeding internally as well as externally.
Application Insights:
Based on the application, the global blood product market is segmented into immunity, therapy, surgery and others. The immunity segment dominated the overall market in terms of revenue share in 2017. Immunity products are used to stimulate and boost the immune system when it is weak or not functioning properly. This can be done by directly stimulating white blood cells (WBCs) or by increasing antibodies.
The growing use of immunoglobulins for passive antibody therapy as well as active antibody replacement therapies has led to an increased demand for blood products across the globe. Increasingly sophisticated methods for delivering nucleic acids that augment humoral and cellular responses also support this growth segment¢â‚¬â„¢s dominance over other applications during recent years (last few decades).
Regional Analysis:
North America dominated the global blood product market in 2017. The presence of well-established healthcare facilities, favorable reimbursement policies, and increasing R&D activities are some of the major factors contributing to its growth. In addition, growing number of collection centers for donations is also expected to boost the overall market over the forecast period.
Asia Pacific is anticipated to witness lucrative CAGR during the forecast period owing to rising prevalence of chronic diseases coupled with improving healthcare infrastructure in emerging countries such as China and India. Moreover, rapidly developing medical tourism industry due to low cost associated with treatment in these countries will also drive demand for products over next eight years.
The Middle East & Africa region is projecteded exhibit a high growth rate during this period owing to increasing incidence rates of cancer.
Growth Factors:
- Increasing incidence of chronic diseases such as cancer, diabetes, and heart diseases
- Growing awareness about blood donation and its benefits
- Rising demand for safe and quality blood products
- Technological advancements in the field of blood transfusion and storage
- Expansion of the global healthcare infrastructure
Scope Of The Report
Report Attributes
Report Details
Report Title
Blood Product Market Research Report
By Type
Albumin, Immune Globulin, Coagulation Factor, Others, Blood Produc
By Application
Immunity, Therapy, Surgery, Other
By Companies
Baxter, CSL, Grifols, Octapharma, BPL, Kedrion, Mitsubishi Tanabe, CBOP, RAAS, Hualan Bio, Blood Produc
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Blood Product Market Report Segments:
The global Blood Product market is segmented on the basis of:
Types
Albumin, Immune Globulin, Coagulation Factor, Others, Blood Produc
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Immunity, Therapy, Surgery, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Baxter
- CSL
- Grifols
- Octapharma
- BPL
- Kedrion
- Mitsubishi Tanabe
- CBOP
- RAAS
- Hualan Bio
- Blood Produc
Highlights of The Blood Product Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Albumin
- Immune Globulin
- Coagulation Factor
- Others
- Blood Produc
- By Application:
- Immunity
- Therapy
- Surgery
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Blood Product Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A blood product is a medication or other biological substance that is derived from the blood of an animal.
Some of the major companies in the blood product market are Baxter, CSL, Grifols, Octapharma, BPL, Kedrion, Mitsubishi Tanabe, CBOP, RAAS, Hualan Bio, Blood Produc.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Blood Product Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Blood Product Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Blood Product Market - Supply Chain
4.5. Global Blood Product Market Forecast
4.5.1. Blood Product Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Blood Product Market Size (000 Units) and Y-o-Y Growth
4.5.3. Blood Product Market Absolute $ Opportunity
5. Global Blood Product Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Blood Product Market Size and Volume Forecast by Type
5.3.1. Albumin
5.3.2. Immune Globulin
5.3.3. Coagulation Factor
5.3.4. Others
5.3.5. Blood Produc
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Blood Product Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Blood Product Market Size and Volume Forecast by Application
6.3.1. Immunity
6.3.2. Therapy
6.3.3. Surgery
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Blood Product Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Blood Product Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Blood Product Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Blood Product Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Blood Product Demand Share Forecast, 2019-2026
9. North America Blood Product Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Blood Product Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Blood Product Market Size and Volume Forecast by Application
9.4.1. Immunity
9.4.2. Therapy
9.4.3. Surgery
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Blood Product Market Size and Volume Forecast by Type
9.7.1. Albumin
9.7.2. Immune Globulin
9.7.3. Coagulation Factor
9.7.4. Others
9.7.5. Blood Produc
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Blood Product Demand Share Forecast, 2019-2026
10. Latin America Blood Product Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Blood Product Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Blood Product Market Size and Volume Forecast by Application
10.4.1. Immunity
10.4.2. Therapy
10.4.3. Surgery
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Blood Product Market Size and Volume Forecast by Type
10.7.1. Albumin
10.7.2. Immune Globulin
10.7.3. Coagulation Factor
10.7.4. Others
10.7.5. Blood Produc
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Blood Product Demand Share Forecast, 2019-2026
11. Europe Blood Product Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Blood Product Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Blood Product Market Size and Volume Forecast by Application
11.4.1. Immunity
11.4.2. Therapy
11.4.3. Surgery
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Blood Product Market Size and Volume Forecast by Type
11.7.1. Albumin
11.7.2. Immune Globulin
11.7.3. Coagulation Factor
11.7.4. Others
11.7.5. Blood Produc
11.8. Basis Point Share (BPS) Analysis by Type
11.9 Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Blood Product Demand Share, 2019-2026
12. Asia Pacific Blood Product Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Blood Product Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Blood Product Market Size and Volume Forecast by Application
12.4.1. Immunity
12.4.2. Therapy
12.4.3. Surgery
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Blood Product Market Size and Volume Forecast by Type
12.7.1. Albumin
12.7.2. Immune Globulin
12.7.3. Coagulation Factor
12.7.4. Others
12.7.5. Blood Produc
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Blood Product Demand Share, 2019-2026
13. Middle East & Africa Blood Product Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Blood Product Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Blood Product Market Size and Volume Forecast by Application
13.4.1. Immunity
13.4.2. Therapy
13.4.3. Surgery
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Blood Product Market Size and Volume Forecast by Type
13.7.1. Albumin
13.7.2. Immune Globulin
13.7.3. Coagulation Factor
13.7.4. Others
13.7.5. Blood Produc
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Blood Product Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Blood Product Market: Market Share Analysis
14.2. Blood Product Distributors and Customers
14.3. Blood Product Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Baxter
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. CSL
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Grifols
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Octapharma
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. BPL
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Kedrion
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Mitsubishi Tanabe
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. CBOP
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. RAAS
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Hualan Bio
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Blood Produc
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook